DK1501499T3 - Transepikutan indgivelsesform til behandling af restless legs-syndromet - Google Patents
Transepikutan indgivelsesform til behandling af restless legs-syndrometInfo
- Publication number
- DK1501499T3 DK1501499T3 DK03727432T DK03727432T DK1501499T3 DK 1501499 T3 DK1501499 T3 DK 1501499T3 DK 03727432 T DK03727432 T DK 03727432T DK 03727432 T DK03727432 T DK 03727432T DK 1501499 T3 DK1501499 T3 DK 1501499T3
- Authority
- DK
- Denmark
- Prior art keywords
- restless leg
- leg syndrome
- treatment
- administration
- transepicutaneous
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10220230A DE10220230A1 (de) | 2002-05-06 | 2002-05-06 | Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms |
PCT/EP2003/004685 WO2003092677A1 (de) | 2002-05-06 | 2003-05-05 | Transepikutane darreichungsform zur behandlung des restless leg syndroms |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1501499T3 true DK1501499T3 (da) | 2008-06-23 |
Family
ID=29285132
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03727432T DK1501499T3 (da) | 2002-05-06 | 2003-05-05 | Transepikutan indgivelsesform til behandling af restless legs-syndromet |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1501499B1 (ru) |
JP (2) | JP5253707B2 (ru) |
KR (1) | KR20040104697A (ru) |
CN (1) | CN100396281C (ru) |
AT (1) | ATE387912T1 (ru) |
AU (1) | AU2003233233B2 (ru) |
BR (1) | BR0309837A (ru) |
CA (2) | CA2787384A1 (ru) |
CY (1) | CY1107452T1 (ru) |
DE (2) | DE10220230A1 (ru) |
DK (1) | DK1501499T3 (ru) |
ES (1) | ES2301795T3 (ru) |
HK (1) | HK1072541A1 (ru) |
IL (2) | IL164861A0 (ru) |
MX (1) | MXPA04010687A (ru) |
NO (1) | NO333619B1 (ru) |
NZ (1) | NZ536533A (ru) |
PL (1) | PL218549B1 (ru) |
PT (1) | PT1501499E (ru) |
RU (1) | RU2301063C9 (ru) |
SI (1) | SI1501499T1 (ru) |
UA (1) | UA81625C2 (ru) |
WO (1) | WO2003092677A1 (ru) |
ZA (1) | ZA200408862B (ru) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10359528A1 (de) * | 2003-12-18 | 2005-07-28 | Schwarz Pharma Ag | (S)-2-N-Propylamino-5-hydroxytetralin als D3-agonistisches Therapeutikum |
WO2007129427A1 (ja) * | 2006-05-08 | 2007-11-15 | Teikoku Seiyaku Co., Ltd. | 抗認知症薬物の経皮吸収製剤 |
TWI392670B (zh) * | 2006-06-22 | 2013-04-11 | Ucb Pharma Gmbh | 經取代的2-胺基萘滿之於製造用於預防、減緩及/或治療各種類型疼痛之藥物上的用途 |
EP1987815A1 (en) * | 2007-05-04 | 2008-11-05 | Schwarz Pharma Ag | Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders |
US8592477B2 (en) | 2007-11-28 | 2013-11-26 | Ucb Pharma Gmbh | Polymorphic form of rotigotine and process for production |
US8580281B2 (en) | 2008-02-27 | 2013-11-12 | Hisamitsu Pharmaceutical Co., Inc. | Medicated patch |
ES2661767T3 (es) | 2008-02-27 | 2018-04-03 | Hisamitsu Pharmaceutical Co., Inc. | Parche adhesivo para la piel y producto envasado |
EP2201941A1 (de) | 2008-12-29 | 2010-06-30 | UCB Pharma GmbH | Pflaster-Herstellungstechnologie |
EP2281559A1 (en) | 2009-06-26 | 2011-02-09 | UCB Pharma GmbH | Pharmaceutical composition comprising rotigotine salts (acid or Na), especially for iontophoresis |
DK2515887T3 (en) * | 2009-12-22 | 2018-09-17 | Ucb Biopharma Sprl | Polyvinylpyrrolidone to stabilize a solid dispersion of the non-crystalline form of rotigotine |
EP2531486B1 (en) | 2010-02-05 | 2017-06-21 | UCB Biopharma SPRL | Novel process for the preparation of nitrogen substituted aminotetralins derivatives |
AU2011268871C1 (en) | 2010-06-25 | 2015-06-04 | Ucb Pharma Gmbh | Processes for the resolution of nitrogen substituted (S) - 5 -alkoxy- 2 -aminotetralin derivatives |
EP2559435A1 (en) | 2011-08-19 | 2013-02-20 | UCB Pharma GmbH | Rotigotine in the treatment of hemispatial neglect, stroke and deficits following stroke |
DE102012013439A1 (de) | 2012-07-03 | 2014-01-23 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Transdermales therapeutisches System umfassend Rotigotin und Kristallisationsinhibitor |
WO2013075822A1 (en) | 2011-11-22 | 2013-05-30 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Transdermal therapeutic system (tts) with rotigotine |
DE102012013421A1 (de) | 2012-07-03 | 2014-01-09 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Transdermales therapeutisches System (TTS) mit Rotigotin |
KR101558042B1 (ko) * | 2012-07-05 | 2015-10-07 | 에스케이케미칼주식회사 | 로티고틴을 함유한 경피흡수제제 |
WO2014007597A1 (ko) * | 2012-07-06 | 2014-01-09 | 에스케이케미칼(주) | 로티고틴 함유 경피흡수제제 |
TW201431570A (zh) | 2012-11-22 | 2014-08-16 | Ucb Pharma Gmbh | 用於經皮投服羅替戈汀(Rotigotine)之多天式貼片 |
CA2916183C (en) | 2013-07-03 | 2022-03-29 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system with electronic component |
US10045948B2 (en) | 2014-02-27 | 2018-08-14 | Medrx Co., Ltd. | Pramipexole-containing transdermal patch for treatment of neurodegenerative disease |
CA2948221C (en) | 2014-05-20 | 2022-11-22 | Lts Lohmann Therapie-Systeme Ag | Transdermal delivery system including an interface mediator |
CN106456566B (zh) | 2014-05-20 | 2020-06-16 | Lts勒曼治疗系统股份公司 | 含罗替戈汀的经皮递送系统 |
CN106456567A (zh) | 2014-05-20 | 2017-02-22 | Lts勒曼治疗系统股份公司 | 在经皮递送系统中调节活性剂释放的方法 |
WO2020250840A1 (ja) | 2019-06-14 | 2020-12-17 | 久光製薬株式会社 | ロチゴチン含有貼付剤 |
DK3854388T3 (da) | 2020-01-24 | 2023-11-27 | Luye Pharma Switzerland Ag | Transdermalt terapeutisk system omfattende rotigotin og mindst et ikke-aminresistent silikoneklæbestof |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5474783A (en) * | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US5232702A (en) * | 1991-07-22 | 1993-08-03 | Dow Corning Corporation | Silicone pressure sensitive adhesive compositons for transdermal drug delivery devices and related medical devices |
IL116539A (en) * | 1995-01-06 | 2002-02-10 | Noven Pharma | Preparations given through the skin of unstable anti-acid drugs |
FR2749514B1 (fr) * | 1996-06-11 | 1998-08-07 | Hoechst Marion Roussel | Systemes transdermiques renfermant 2 principes actifs dans des compartiments separes, leur procede de preparation et leur application comme medicament |
DE19701619B4 (de) * | 1997-01-17 | 2007-10-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von Pramipexol zur Behandlung des restless legs syndroms |
DE19814084B4 (de) * | 1998-03-30 | 2005-12-22 | Lts Lohmann Therapie-Systeme Ag | D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung |
DE19938823A1 (de) * | 1999-08-19 | 2001-02-22 | Boehringer Ingelheim Pharma | Medikamentöse Behandlung des Restless Leg Syndroms |
DE19938825A1 (de) * | 1999-08-19 | 2001-04-26 | Boehringer Ingelheim Pharma | Wirkstoffkombination mit Clonidin |
DE10041479A1 (de) * | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923 |
EP1256339B1 (en) * | 2001-05-08 | 2003-10-15 | Schwarz Pharma Ag | Transdermal therapeutic system for Parkinson's disease inducing high plasma levels of rotigotine |
DE60100595T2 (de) * | 2001-05-08 | 2004-06-24 | Lts Lohmann Therapie-Systeme Ag | Verbessertes transdermales therapeutisches System zur Behandlung von Morbus Parkinson |
-
2002
- 2002-05-06 DE DE10220230A patent/DE10220230A1/de not_active Ceased
-
2003
- 2003-05-05 IL IL16486103A patent/IL164861A0/xx unknown
- 2003-05-05 CA CA2787384A patent/CA2787384A1/en not_active Abandoned
- 2003-05-05 KR KR10-2004-7017685A patent/KR20040104697A/ko not_active Application Discontinuation
- 2003-05-05 PT PT03727432T patent/PT1501499E/pt unknown
- 2003-05-05 SI SI200331195T patent/SI1501499T1/sl unknown
- 2003-05-05 ES ES03727432T patent/ES2301795T3/es not_active Expired - Lifetime
- 2003-05-05 AT AT03727432T patent/ATE387912T1/de active
- 2003-05-05 NZ NZ536533A patent/NZ536533A/en not_active IP Right Cessation
- 2003-05-05 DK DK03727432T patent/DK1501499T3/da active
- 2003-05-05 CA CA2483120A patent/CA2483120C/en not_active Expired - Fee Related
- 2003-05-05 MX MXPA04010687A patent/MXPA04010687A/es active IP Right Grant
- 2003-05-05 JP JP2004500861A patent/JP5253707B2/ja not_active Expired - Lifetime
- 2003-05-05 PL PL373276A patent/PL218549B1/pl unknown
- 2003-05-05 DE DE50309318T patent/DE50309318D1/de not_active Expired - Lifetime
- 2003-05-05 WO PCT/EP2003/004685 patent/WO2003092677A1/de active IP Right Grant
- 2003-05-05 AU AU2003233233A patent/AU2003233233B2/en not_active Ceased
- 2003-05-05 RU RU2004131866/15A patent/RU2301063C9/ru active
- 2003-05-05 BR BR0309837-0A patent/BR0309837A/pt not_active Application Discontinuation
- 2003-05-05 CN CNB038160250A patent/CN100396281C/zh not_active Expired - Fee Related
- 2003-05-05 EP EP03727432A patent/EP1501499B1/de not_active Revoked
- 2003-05-05 UA UA20041109078A patent/UA81625C2/ru unknown
-
2004
- 2004-10-27 IL IL164861A patent/IL164861A/en active IP Right Grant
- 2004-11-02 ZA ZA2004/08862A patent/ZA200408862B/en unknown
- 2004-11-30 NO NO20045240A patent/NO333619B1/no not_active IP Right Cessation
-
2005
- 2005-06-22 HK HK05105199A patent/HK1072541A1/xx not_active IP Right Cessation
-
2008
- 2008-05-02 CY CY20081100471T patent/CY1107452T1/el unknown
-
2010
- 2010-04-22 JP JP2010098924A patent/JP2010159302A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1107452T1 (el) | Διαδερμικη μορφη χορηγησης για τη θεραπεια του συνδρομου ανησυχων ποδιων | |
SG146643A1 (en) | Treating or preventing restless legs syndrome using prodrugs of gaba analogs | |
DK1587506T3 (da) | Administration af capsaicinoider | |
NO20024586L (no) | FremgangsmÕte og preparat for prevensjon av hormoninduserte ugunstige virkninger | |
BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
MY140576A (en) | Cannabinoid active pharmaceutical ingredient for improved dosage forms | |
DK1539166T3 (da) | Farmaceutiske sammensætninger indeholdende dextromethorphan og quinidin til behandling af neurologiske sygdomme | |
DK1363608T3 (da) | Formuleringer omfattende ibuprofen og diphenhydramin og deres anvendelse til behandling af sovnforstyrrelser | |
DE602005024571D1 (de) | Opioide zur behandlung von ruhelosigkeit in den unteren gliedmassen | |
MY169275A (en) | Method of immunization against the four serotypes of dengue | |
HK1074592A1 (en) | 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
RU2003133217A (ru) | Чрескожная терапевтическая система для лечения болезни паркинсона, индуцирующая высокие уровни ротиготина в плазме | |
TW200517107A (en) | Novel formulation | |
WO2004012655A3 (en) | Anti-microbial compositions and methods of using same | |
DE60322102D1 (de) | Transdermales buprenorphin-dosierschema zwecks schmerzstillung | |
DK1303278T3 (da) | Kombination af et transdermalt terapeutisk system og et oralt og/eller parenteralt præparat indeholdende dopaminagonister til behandling af dopaminerge sygdomme | |
DK1154795T3 (da) | Middel til behandling af diagnosticering af restless legs syndrom | |
MY130792A (en) | 17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES | |
TW200618807A (en) | Prevention and therapeutical agent for hepatitis C virus infection | |
EA200700979A1 (ru) | Пероральные твердые лекарственные формы, содержащие низкую дозу эстрадиола | |
HRP20070441T3 (en) | Pharmaceutical combination for the treatment of spasticity and/or pain | |
SE0203817D0 (sv) | New composition | |
DE60236443D1 (de) | Inhibitoren der kostimulation via ox40 und deren verwendung gegen eine von virusen induzierten immunpathologie | |
MXPA04006269A (es) | Composicion farmaceutica que comprende un inhibidor de alfa-glucosidasa y acido 4-oxobutanoico y uso de la misma para tratamiento de diabetes. | |
HUP0402645A2 (hu) | Egy glitazont és egy 4-oxobutánsavat tartalmazó gyógyászati készítmény és ennek alkalmazása cukorbetegség kezelésére |